Slater supports biopharma and biotech companies in their business development and commercialization strategy. He partners with companies focused on commercial assessments, business development and new product planning strategy, pipeline/portfolio prioritization and strategy, and launch roadmap planning, bringing deep experience in rare diseases. Clients leverage Slater’s insights in navigating early- to mid- clinical stage product development opportunities and the commercial needs required to recognize their full potential.
Prior to joining ClearView, Slater spent several years working in a translational hematology/oncology research lab in the Boston area. Slater holds a B.A. from Duke University and a M.S. from Boston University.
Debbi Amanti Belanger
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Dean Griffiths
Slater Hurst
Ketan Kapadia
Philip Kenner
Eva Kersey
Jessica Lee
Stuart MacGregor
Charles Mathews
David McClain
Richard Mynahan
Kai-Ming Pu
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Michael Agne
Jonathan Betts
Jonathan Hodgson
Owen Im
Jonny Juliano
Andrew Kang
Dave Konciak
Alexander Lehrman
Matthew Pfister
Olivia Piccione
Sarah Stapleton
Brian Quinn
Kelsey Yardumian
Jake Arakal
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Cem Salfati
Soyeon Park
Lainey Miller
Jim Duffy
Melanie Robinson